IGFBP7 and acute kidney injury: This is in contrast with several other research findings that showed urine [TIMP-2]·[IGFBP7] accurately predicts AKI in critically ill, platinum-treated or high-risk surgical patients and suggest that different biomarker or biomarker panels should be used in different patient groups19.